Effects of statin medication and cardiovascular disease on pulp chamber calcification - A 3-dimensional radiographic analysis on Indian populatio
Not Applicable
- Registration Number
- CTRI/2024/06/069197
- Lead Sponsor
- eha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patient with 30 to 45 years of age and presence of healthy either first or second mandibular molars
group 1 healthy patient
group 2 cardiovascular patient
group 3 cardiovascular patient taking statin medication
Exclusion Criteria
CBCT scan with the presence of caries large restorations attrition periodontitis previous pulp cap treated teeth endodontically treated teeth patients with history of clenching or grinding group 1 patients with any systemic disease group 2 and 3 patients with systemic disease like renal lithiasis gout cholelithiasis diabetes mellitus were excluded from the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient with cardiovascular <br/ ><br>disease taking statin <br/ ><br>medication may have <br/ ><br>increased incidence of pulp <br/ ><br>chamber calcification <br/ ><br>followed by cardiovascular <br/ ><br>patient without taking any <br/ ><br>medication compared to healthy individualTimepoint: patients taking statin medication for more than 5 years <br/ ><br>patients having cardiovascular disease more than 5 years
- Secondary Outcome Measures
Name Time Method Patient with cardiovascular <br/ ><br>disease taking statin <br/ ><br>medication may have <br/ ><br>increased incidence of pulp <br/ ><br>chamber calcification <br/ ><br>followed by cardiovascular <br/ ><br>patient without taking any <br/ ><br>medication compared to healthy individualTimepoint: Patient with cardiovascular <br/ ><br>disease for more than 5 years